{"id":"https://openalex.org/W3212425883","doi":"https://doi.org/10.1182/blood-2021-149847","title":"Incidence, Risk Factors and Outcomes of Pulmonary Embolism in Philadelphia Negative Myeloproliferative Neoplasms: A Population Based Study","display_name":"Incidence, Risk Factors and Outcomes of Pulmonary Embolism in Philadelphia Negative Myeloproliferative Neoplasms: A Population Based Study","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3212425883","doi":"https://doi.org/10.1182/blood-2021-149847","mag":"3212425883"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-149847","doi":"https://doi.org/10.1182/blood-2021-149847","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-149847","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068715172","display_name":"Luis Fernando Gonzalez-Mosquera","orcid":"https://orcid.org/0000-0002-2010-4232","observed_orcids":["https://orcid.org/0000-0002-2010-4232"]},"institutions":[{"id":"https://openalex.org/I2801317995","display_name":"Nassau University Medical Center","ror":"https://ror.org/03cc0mm23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801317995"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luis F. Gonzalez-Mosquera","raw_affiliation_strings":["Department of Internal Medicine, Nassau University Medical Center, East Meadow, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Nassau University Medical Center, East Meadow, NY","institution_ids":["https://openalex.org/I2801317995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041723800","display_name":"Bernard Moscoso","orcid":"https://orcid.org/0000-0001-5345-4717","observed_orcids":["https://orcid.org/0000-0001-5345-4717"]},"institutions":[{"id":"https://openalex.org/I2135383","display_name":"Escuela Superior Politecnica del Litoral","ror":"https://ror.org/04qenc566","country_code":"EC","type":"education","lineage":["https://openalex.org/I2135383"]}],"countries":["EC"],"is_corresponding":false,"raw_author_name":"Bernard Moscoso","raw_affiliation_strings":["Centro de Investigaciones Econ\u00f3micas, Escuela Superior Polit\u00e9cnica del Litoral, ESPOL, Guayaquil, Ecuador"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaciones Econ\u00f3micas, Escuela Superior Polit\u00e9cnica del Litoral, ESPOL, Guayaquil, Ecuador","institution_ids":["https://openalex.org/I2135383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065085432","display_name":"Diana D D Cardenas-Maldonado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801317995","display_name":"Nassau University Medical Center","ror":"https://ror.org/03cc0mm23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801317995"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana Cardenas-Maldonado","raw_affiliation_strings":["Department of Internal Medicine, Nassau University Medical Center, East Meadow, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Nassau University Medical Center, East Meadow, NY","institution_ids":["https://openalex.org/I2801317995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055652606","display_name":"Pool Tobar","orcid":"https://orcid.org/0000-0003-2514-5946","observed_orcids":["https://orcid.org/0000-0003-2514-5946"]},"institutions":[{"id":"https://openalex.org/I4210122734","display_name":"Advocate Illinois Masonic Medical Center","ror":"https://ror.org/036vtmj33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088488","https://openalex.org/I4210122734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pool Tobar","raw_affiliation_strings":["Department of Internal Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL","institution_ids":["https://openalex.org/I4210122734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084174428","display_name":"Alida I. Podrumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801317995","display_name":"Nassau University Medical Center","ror":"https://ror.org/03cc0mm23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801317995"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alida I. Podrumar","raw_affiliation_strings":["Department of Hematology and Oncology, Nassau University Medical Center, East Meadow, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nassau University Medical Center, East Meadow, NY","institution_ids":["https://openalex.org/I2801317995"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091042349","display_name":"John A. Cuenca","orcid":"https://orcid.org/0000-0003-3228-2244","observed_orcids":["https://orcid.org/0000-0003-3228-2244"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Cuenca","raw_affiliation_strings":["Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"3654","last_page":"3654"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9390000104904175,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9390000104904175,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.06069999933242798,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pulmonary-embolism","display_name":"pulmonary embolism","score":0.9819999933242798},{"id":"https://openalex.org/keywords/philadelphia-chromosome-negative-myeloproliferative-neoplasms","display_name":"Philadelphia-negative myeloproliferative neoplasms","score":0.9779999852180481},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":0.8669999837875366},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":0.9179999828338623},{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9729999899864197},{"id":"https://openalex.org/keywords/thrombosis-risk-factors","display_name":"thrombosis risk factors","score":0.7509999871253967},{"id":"https://openalex.org/keywords/in-hospital-mortality","display_name":"in-hospital mortality","score":0.8999999761581421},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.46799999475479126},{"id":"https://openalex.org/keywords/socioeconomic-factors","display_name":"socioeconomic factors","score":0.5260000228881836},{"id":"https://openalex.org/keywords/nationwide-inpatient-sample","display_name":"National Inpatient Sample","score":0.6010000109672546},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.6600000262260437},{"id":"https://openalex.org/keywords/endothelial-injury","display_name":"endothelial injury","score":0.8399999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8944282531738281},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.6857254505157471},{"id":"https://openalex.org/C2776265017","wikidata":"https://www.wikidata.org/wiki/Q220570","display_name":"Pulmonary embolism","level":2,"score":0.6830401420593262},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.646059513092041},{"id":"https://openalex.org/C2779788118","wikidata":"https://www.wikidata.org/wiki/Q1542410","display_name":"Thrombocytosis","level":3,"score":0.6362794041633606},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6026312708854675},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.5627057552337646},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.5402265787124634},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.49874401092529297},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.4197034537792206},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.41700899600982666},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.38342148065567017},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.0},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-149847","doi":"https://doi.org/10.1182/blood-2021-149847","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-149847","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4328136560","https://openalex.org/W2890913979","https://openalex.org/W7116602137","https://openalex.org/W4413900968","https://openalex.org/W7108478459","https://openalex.org/W2959055558","https://openalex.org/W2998667151","https://openalex.org/W2563770732","https://openalex.org/W2931448596","https://openalex.org/W2953544537"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Thromboembolism":[2],"is":[3],"a":[4,120,199,208,270,282,324,338,357,401,420,447],"well-recognized":[5],"complication":[6],"of":[7,25,75,87,96,123,156,190,215,261,273,307,327,360,450,496,522,556],"patients":[8,125,140,160,191,257,298,314,371,397,478],"with":[9,40,117,142,161,172,192,207,212,233,258,334,391,398,415,444,479,493],"Philadelphia":[10],"negative":[11],"myeloproliferative":[12],"neoplasms":[13],"(MPN),":[14],"potentially":[15],"due":[16],"to":[17,35,107,127,138,151,186,373,395,505,541,558],"an":[18],"endothelial":[19],"injury":[20],"caused":[21],"by":[22],"the":[23,29,37,57,84,133,148,153,179,183,188,213,218,224,229,319,369,378,441,462,494,506,520],"activation":[24],"inflammatory":[26],"cytokines.":[27],"Among":[28,254],"MPNs,":[30],"Polycythemia":[31],"vera":[32],"(PV)":[33],"seemed":[34],"be":[36],"most":[38,260],"associated":[39,116,171,232,390,414,492],"thrombotic":[41],"events;":[42],"however,":[43,94],"essential":[44],"thrombocytosis":[45],"(ET)":[46],"and":[47,62,158,162,174,182,193,205,268,294,299,312,356,429,458,481,501,514,538],"primary":[48],"myelofibrosis":[49],"(PMF)":[50],"are":[51],"also":[52,336],"at":[53],"higher":[54,67,305,339,358,416,448,459,484],"risk":[55,169,230],"than":[56,461,486],"general":[58],"population.":[59,547],"Furthermore,":[60],"arterial":[61],"venous":[63,88],"thromboembolisms":[64],"account":[65],"for":[66,223,404,418,439],"mortality":[68,460,485],"in":[69,119,217,292,318,368,529,544],"this":[70,471,517,545],"population,":[71],"causing":[72],"approximately":[73],"45%":[74],"all":[76,440],"disease-associated":[77],"fatal":[78],"events.":[79],"Previous":[80],"studies":[81,533],"have":[82],"explored":[83],"combined":[85],"outcomes":[86,167,189],"thromboembolism":[89],"(VTE)":[90],"on":[91,100],"MPN":[92,124,143,157,480,530],"patients;":[93],"none":[95],"them":[97,262],"focused":[98],"primarily":[99],"pulmonary":[101],"embolism":[102],"(PE).":[103],"Therefore,":[104],"we":[105,475],"aimed":[106],"identify":[108,139,152],"any":[109],"potential":[110],"demographic,":[111],"socioeconomic,":[112],"or":[113,384],"clinical":[114],"characteristics":[115,204],"PE":[118,173,216,234,283,297,320,335,370,392,406,421,445,482,497,543],"large":[121,472],"cohort":[122],"admitted":[126],"US":[128],"hospitals.":[129],"Methods:":[130],"We":[131,146,177,196,227],"inquired":[132],"Nationwide":[134],"Inpatient":[135],"Sample":[136],"database":[137],"diagnosed":[141],"from":[144],"2016-2018.":[145],"used":[147],"ICD-10":[149],"codes":[150],"different":[154],"types":[155],"compare":[159,187],"without":[163,194,375,488],"PE.":[164,195,376,489],"The":[165,412],"main":[166],"were":[168,221,241,263,288,304,349,387,422,498],"factors":[170,231,491,525],"in-hospital":[175],"mortality.":[176],"computed":[178],"chi-squared":[180],"test":[181],"Mann-Whitney":[184],"U-test":[185],"first":[197],"conducted":[198,242],"univariate":[200,219],"analysis.":[201],"Clinically":[202],"relevant":[203,554],"variables":[206],"significant":[209,290],"association":[210],"(p<0.05)":[211],"development":[214,495],"analysis":[220],"considered":[222],"multivariate":[225,236,379],"model.":[226],"identified":[228,256],"using":[235,243],"logistic":[237],"regression.":[238],"Our":[239],"analyses":[240],"Stata":[244],"Statistical":[245],"Software":[246],"version":[247],"14":[248],"(StataCorp,":[249],"College":[250],"Station,":[251],"TX).":[252],"Results:":[253],"82,087":[255],"MPN,":[259],"white":[264],"(67.4%),":[265],"female":[266],"(54.6%),":[267],"had":[269,281,337,400,446,483],"median":[271,340],"age":[272,293],"63":[274],"(IQR":[275],"49-76).":[276],"Of":[277],"them,":[278],"1982":[279],"(2.4%)":[280],"event":[284],"during":[285],"admission.":[286],"There":[287,348],"no":[289],"differences":[291],"sex":[295],"between":[296],"non-PE":[300,463],"patients.":[301,531],"While":[302],"there":[303,322],"proportions":[306],"White":[308],"(68.3%":[309],"vs.":[310,316,330,345,354,365,454,466],"67.4%)":[311],"Black":[313],"(18.6%":[315],"17%)":[317],"group,":[321],"was":[323],"lower":[325],"proportion":[326,359],"Hispanics":[328],"(8.7%":[329],"9.7%;":[331],"p=0.007).":[332],"Patients":[333,443],"Elixhauser":[341],"comorbidity":[342],"index":[343],"(5":[344],"4,":[346],"p<0.001).":[347,468],"fewer":[350],"Medicare":[351],"beneficiaries":[352],"(48.5%":[353],"52.4%)":[355],"private":[361],"insurance":[362],"usage":[363],"(26.8%":[364],"22.3%;":[366],"p<0.001)":[367,457],"compared":[372],"those":[374,487],"In":[377,470,503],"analysis,":[380],"age,":[381],"sex,":[382],"race,":[383],"income":[385],"quartile":[386],"not":[388],"significantly":[389],"development.":[393],"Compared":[394],"PV,":[396],"PMF":[399],"protective":[402],"effect":[403],"developing":[405],"(OR:":[407,424,431],"0.35;":[408],"CI":[409,426,433],"95%:":[410,427,434],"0.22-0.54).":[411],"comorbidities":[413],"odds":[417],"having":[419],"coagulopathies":[423],"1.99;":[425],"1.71-2.30)":[428],"obesity":[430,500,528],"1.47;":[432],"1.29-1.67).":[435],"See":[436],"Table":[437],"1":[438,549],"variables.":[442],"length":[449],"stay":[451],"(6":[452],"days":[453],"5":[455],"days;":[456],"group":[464],"(6.1%":[465],"2.8%;":[467],"Conclusions:":[469],"epidemiological":[473],"study,":[474],"found":[476],"that":[477],"Risk":[490],"concomitant":[499],"coagulopathy.":[502],"addition":[504],"known":[507],"preventive":[508],"therapies":[509],"such":[510,526],"as":[511,527],"aspirin,":[512],"phlebotomy,":[513],"cytoreductive":[515],"agents,":[516],"study":[518],"highlights":[519],"importance":[521],"controlling":[523],"modifiable":[524],"Future":[532],"should":[534],"confirm":[535],"our":[536],"findings":[537],"investigate":[539],"strategies":[540],"prevention":[542],"vulnerable":[546],"Figure":[548,550],"1.":[551],"Disclosures":[552],"No":[553],"conflicts":[555],"interest":[557],"declare.":[559]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-11-22T00:00:00"}